Nordic HTA Initiative Offers ‘Practice Ground’ For Worrisome EU-Level Joint Clinical Assessment

 
• By Francesca Bruce
  
Generate a summary of this article
Listen to this article
Beta

Industry shoulders some blame for growing unease about joint clinical assessments after its failure to participate in pilots.

NORDIC FLAGS
Nordic countries offer companies the chance to prepare for EU joint clinical assessments • Source: Shutterstock

Concern continues to grow among industry and health technology assessment (HTA) bodies about the imminent EU-wide joint clinical assessments. However, if companies want to increase their chances of readiness for the challenges ahead, they should consider submitting a dossier through the Joint Nordic HTA-Bodies (JNHB) initiative to get a taste of how the collaborative assessment process might work.

This was the message from Anja Schiel and Karen Kleberg Hansen, from the Norwegian Medical Products Agency and the Danish...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

EU Biosimilar Filings, Opinions And Approvals

 
• By Saba Afreen

<p>Executive Summary</p> <p>A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.</p>

EU Pharma Reform: What You Need to Know Now

 
• By Anabel Costa-Ferreira and Ian Schofield

As the reform of the EU pharmaceutical legislation progresses through the legislative process, the Pinks Sheet offers an infographic highlighting some of the key changes being proposed that will reshape the way drug companies run their business.

New EU Approvals

<p>Executive Summary<p> <p>The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add six new products, incl/ding Ixchiq, Valneva's chikungunya virus vaccine</p>

More from Geography

Canada Cuts Red Tape With Single Ethics Review For Trials

A new research ethics review system for multi-site clinical trials in Canada is expected to help improve study start-up times, avoid unnecessary duplication and boost the country’s competitiveness on a global stage.

Nancy Test Circulable Section Geography

 
• By Brian Bossetta

This is a short description

Diversity Action Plans: What To Submit And When

 
• By Nielsen Hobbs

With the deadline for comments on the US FDA’s draft guidance less than a month away, the Pink Sheet offers an infographic outlining what the agency is expecting in diversity action plans and when that might be implemented.